HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.

Abstract
The necrosis of EMT-6 mammary murine tumors induced by photodynamic therapy (PDT) with Photofrin (PII) or disulfonated aluminum phthalocyanine (AlPcS2) was studied. Attention was given to the spontaneous evolution of angiogenesis and necrosis of such tumors in order to determine the most appropriate moment for treatment. On day 6 after tumor cell inoculation, mice were injected with photosensitizer followed by exposure to red light 24 h later, at which time optimal dye concentrations were reached in the tumor. Animals were sacrificed 3 h or 24 h after illumination and tissues were prepared for histology. Prominent cytopathic alterations were already observed at 3 h and there was massive necrosis at 24 h. In the case of PII vascular damage, congestion and hemorrhage were already present at 3 h and these changes account for the subsequent tumor necrosis through hemorrhagic infarction. With AlPcS2 these early vascular alterations were much less evident and only focal at 24 h, suggesting that AlPcS2-PDT mediated tumor necrosis involves to a large extent direct tumor cell damage.
AuthorsP Margaron, P Madarnas, R Quellet, J E Van Lier
JournalAnticancer research (Anticancer Res) 1996 Mar-Apr Vol. 16 Issue 2 Pg. 613-20 ISSN: 0250-7005 [Print] Greece
PMID8687105 (Publication Type: Journal Article)
Chemical References
  • Indoles
  • Organometallic Compounds
  • Photosensitizing Agents
  • aluminum phthalocyanine
  • Dihematoporphyrin Ether
Topics
  • Animals
  • Dihematoporphyrin Ether (therapeutic use)
  • Hematoporphyrin Photoradiation
  • Indoles (pharmacokinetics, therapeutic use)
  • Male
  • Mammary Neoplasms, Experimental (blood supply, drug therapy, metabolism, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Necrosis
  • Neoplasm Transplantation
  • Organometallic Compounds (pharmacokinetics, therapeutic use)
  • Photosensitizing Agents (therapeutic use)
  • Pigmentation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: